Literature DB >> 23179881

Multifunctional magnetic resonance imaging probes.

Ewelina Kluza1, Gustav J Strijkers, Klaas Nicolay.   

Abstract

Magnetic resonance imaging (MRI) is a key imaging modality in cancer diagnostics and therapy monitoring. MRI-based tumor detection and characterization is commonly achieved by exploiting the compositional, metabolic, cellular, and vascular differences between malignant and healthy tissue. Contrast agents are frequently applied to enhance this contrast. The last decade has witnessed an increasing interest in novel multifunctional MRI probes. These multifunctional constructs, often of nanoparticle design, allow the incorporation of multiple imaging agents for complementary imaging modalities as well as anti-cancer drugs for therapeutic purposes. The composition, size, and surface properties of such constructs can be tailored as to improve biodistribution and ensure optimal delivery to the tumor microenvironment by passive or targeted mechanisms. Multifunctional MRI probes hold great promise to facilitate more specific tumor diagnosis, patient-specific treatment planning, the monitoring of local drug delivery, and the early evaluation of therapy. This chapter reviews the state-of-the-art and new developments in the application of multifunctional MRI probes in oncology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23179881     DOI: 10.1007/978-3-642-10853-2_5

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  3 in total

Review 1.  Assessing the barriers to image-guided drug delivery.

Authors:  Gregory M Lanza; Chrit Moonen; James R Baker; Esther Chang; Zheng Cheng; Piotr Grodzinski; Katherine Ferrara; Kullervo Hynynen; Gary Kelloff; Yong-Eun Koo Lee; Anil K Patri; David Sept; Jan E Schnitzer; Bradford J Wood; Miqin Zhang; Gang Zheng; Keyvan Farahani
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-31

Review 2.  Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.

Authors:  Sijumon Kunjachan; Josef Ehling; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Chem Rev       Date:  2015-07-13       Impact factor: 60.622

3.  Recalcitrant Issues and New Frontiers in Nano-Pharmacology.

Authors:  Vinay Bhardwaj; Ajeet Kaushik; Ziad M Khatib; Madhavan Nair; Anthony J McGoron
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.